Abstract
This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Graphical Abstract
Current Bioactive Compounds
Title:Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract
Volume: 12 Issue: 1
Author(s): Fatah Keffous, Nasser Belboukhari, Houria Djaradi, Abdelkrim Cheriti, Khaled Sekkoum and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Abstract: This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Export Options
About this article
Cite this article as:
Keffous Fatah, Belboukhari Nasser, Djaradi Houria, Cheriti Abdelkrim, Sekkoum Khaled and Y. Aboul-Enein Hassan, Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666160210230707
DOI https://dx.doi.org/10.2174/1573407212666160210230707 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondria-Associated Membranes (MAMs): A Novel Therapeutic Target for Treating Metabolic Syndrome
Current Medicinal Chemistry Controversies on HDL: Should it be a Target Biomarker in Patients with Lipid Disorders?
Current Vascular Pharmacology Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Current Pharmaceutical Design Knowledge and Perceptions Towards Cardiovascular Disease Prevention Among Patients with Type 2 Diabetes Mellitus: A Review of Current Assessments and Recommendations
Current Diabetes Reviews Functionalization of Phenols Using a Biomimetic Couple of Sodium Nitrite/Hydrogen Peroxide in an Acidic Medium
Current Organic Chemistry Ligustrazine Derivatives. Part 8: Design, Synthesis, and Preliminary Biological Evaluation of Novel Ligustrazinyl Amides as Cardiovascular Agents
Medicinal Chemistry The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research Life and Death Partners in Post-PCI Restenosis: Apoptosis, Autophagy, and The Cross-talk Between Them
Current Drug Targets Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design Hypertensive Treatment and the Metabolic Syndrome
Current Hypertension Reviews Risk and Benefit of Statins in Stroke Secondary Prevention
Current Vascular Pharmacology CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Biologic Therapy in Psoriasis: Safety Profile
Current Drug Safety Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes
Current Pharmaceutical Design Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis
Current Pharmaceutical Design Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Serum Vitamin D Concentration and Potential Risk Factors for its Deficiency in HIV Positive Individuals
Current HIV Research The Role of Antiplatelet Therapy in Primary Prevention. A Review
Current Pharmaceutical Design